|
|
Vol. 9.47 – 3 December, 2020
|
|
|
|
|
|
|
|
Glutamine-fructose-6-phosphate transaminase 2 inhibition selectively reduced KRAS/LKB1 co-mutant tumor cell growth in culture, xenografts and genetically modified mice.
[Nature Metabolism]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Investigators used plant-derived cysteine protease, papain to induce asthma in mice and found that interleukin (IL)-28B was capable of alleviating papain-induced asthma. Papain challenge led to activation of epithelial cells and production of alarmin, such as IL-25 and thymic stromal lymphopoietin and IL-28B treatment down-regulated their production.
[Scientific Reports]
|
|
|
|
|
|
Scientists explored the investigative mechanism of salidroside on LPS-induced acute lung injury/acute respiratory distress syndrome.
[Scientific Reports]
|
|
|
|
|
|
Researchers used genomic and structural information to create a biomass function capturing the amino and nucleic acid requirements of SARS-CoV-2. Incorporating this biomass function into a stoichiometric metabolic model of the human lung cell and applying metabolic flux balance analysis, they identified host-based metabolic perturbations inhibiting SARS-CoV-2 reproduction.
[Life Science Alliance]
|
|
|
|
|
|
|
|
Investigators demonstrated that CCL7 facilitates anti-PD-1 therapy for the KrasLSL−G12D/+Tp53fl/fl and the KrasLSL−G12D/+Lkb1fl/fl non-small cell lung cancer mouse models by recruiting conventional DC 1 (cDC1) into the tumor microenvironment to promote T cell expansion.
[Nature Communications]
|
|
|
|
|
|
The authors investigated the effects of coordinate STK11 and KEAP1 loss by comparing co-mutant with single mutant and wild-type isogenic counterparts in multiple lung adenocarcinoma models.
[Cell Reports]
|
|
|
|
|
|
Researchers investigated the potential effect of combining Rovalpituzumab tesirine and CBL0137 in small cell lung cancer to eradicate tumor-initiating cells more effectively.
[British Journal of Cancer]
|
|
|
|
|
|
Knockdown of MELK expression inhibits the migration and invasion of lung adenocarcinoma (LUAD) cells, which may be mediated by Twist1, Slug, MMP7, and N-catenin. Overexpression of MELK promoted the growth of LUAD cells in medium, 3D Matrigel, and nude mice.
[Signal Transduction and Targeted Therapy]
|
|
|
|
|
|
The authors investigated roles of SKIL in tumorigenesis and immune escape of non-small-cell lung cancer (NSCLC). SKIL expression levels in NSCLC cell line, clinical sample, and adjacent normal tissue were measured by quantitative PCR, western blot, or immunohistochemistry.
[Cell Death & Disease]
|
|
|
|
|
|
Investigators characterized a novel circular RNA, circXPO1, in lung adenocarcinoma, which was derived from a well-established cancer therapeutic target, XPO1.
[Cell Death & Disease]
|
|
|
|
|
|
|
|
Initially thought of as a protective cytokine, interleukin-11 is now increasingly recognized as an important determinant of lung fibrosis, inflammation, and epithelial dysfunction.
[Experimental and Molecular Medicine]
|
|
|
|
|
|
|
|
Ipsen announced the FDA has granted the company Fast Track designation for irinotecan liposome injection in study patients with SCLC who progressed following a first-line platinum-based regimen, reflecting the unmet medical need.
[Ipsen]
|
|
|
|
|
|
|
|
May 16 – May 21, 2021
Lucca, Italy
|
|
|
|
|
|
|
|
|
|
|
Columbia University – New York, New York, United States
|
|
|
|
|
|
|
Philipps-Universität Marburg – Marburg, Germany
|
|
|
|
|
|
|
The University of Tennessee Health Science Center – Memphis, Tennessee, United States
|
|
|
|
|
|
|
The University of Texas MD Anderson Cancer Center – Houston, Texas, United States
|
|
|
|
|
|
|
Fred Hutchinson Cancer Research Center – Seattle, Washington, United States
|
|
|
|
|
|